Cost effectiveness of buprenorphine vs. methadone for pregnant people with opioid use disorder

References

• Desai RJ, Hernandez-Diaz S, Bateman BT, et al. Increase in prescription opioid use during pregnancy among medicaid-enrolled women. Obstet Gynecol. 2014;123(5):997–1002.
   PubMed Web of Science ®Google Scholar
• Zelson C, Lee SJ, Casalino M. Neonatal narcotic addiction. Comparative effects of maternal intake of heroin and methadone. N Engl J Med. 1973;289(23):1216–1220.
   PubMed Web of Science ®Google Scholar
• Zedler BK, Mann AL, Kim MM, et al. Buprenorphine compared with methadone to treat pregnant women with opioid use disorder: a systematic review and meta-analysis of safety in the mother, fetus and child. Addiction. 2016;111(12):2115–2128.
   PubMed Web of Science ®Google Scholar
• Fajemirokun-Odudeyi O, Sinha C, Tutty S, et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol. 2006;126(2):170–175.
   PubMed Web of Science ®Google Scholar
• Jones HE, Kaltenbach K, Heil SH, et al. Neonatal abstinence syndrome after methadone or buprenorphine exposure. N Engl J Med. 2010;363(24):2320–2331.
   PubMed Web of Science ®Google Scholar
• Bell JR, Butler B, Lawrance A, et al. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug Alcohol Depend. 2009;104(1–2):73–77.
   PubMed Web of Science ®Google Scholar
• Walsh SL, Eissenberg T. The clinical pharmacology of buprenorphine: extrapolating from the laboratory to the clinic. Drug Alcohol Depend. 2003;70(2 Suppl):S13–S27.
   PubMed Web of Science ®Google Scholar
• Meyer MC, Johnston AM, Crocker AM, et al. Methadone and buprenorphine for opioid dependence during pregnancy: a retrospective cohort study. J Addict Med. 2015;9(2):81–86.
   PubMed Web of Science ®Google Scholar
• Brogly SB, Saia KA, Walley AY, et al. Prenatal buprenorphine versus methadone exposure and neonatal outcomes: systematic review and meta-analysis. Am J Epidemiol. 2014;180(7):673–686.
   PubMed Web of Science ®Google Scholar
• Rodriguez JJ, Smith VC. Epidemiology of perinatal substance use: exploring trends in maternal substance use. Semin Fetal Neonatal Med. 2019;24(2):86–89.
   PubMed Web of Science ®Google Scholar
• Martin JA, Hamilton BE, Osterman MJK, et al. Births: final data for 2015. Natl Vital Stat Rep. 2017;66:1.
   PubMedGoogle Scholar
• Brogly SB, Saia KE, Werler MM, et al. Prenatal treatment and outcomes of women with opioid use disorder. Obstet Gynecol. 2018;132(4):916–922.
   PubMed Web of Science ®Google Scholar
• Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1–9.
   PubMed Web of Science ®Google Scholar
• Vivolo-Kantor AM, Seth P, Gladden RM, et al. Vital signs: trends in emergency department visits for suspected opioid Overdoses - United States, July 2016–September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279–285.
   PubMed Web of Science ®Google Scholar
• Nechanská B, Mravčík V, Skurtveit S, et al. Neonatal outcomes after fetal exposure to methadone and buprenorphine: national registry studies from the Czech Republic and Norway. Addiction. 2018;113(7):1286–1294.
   PubMed Web of Science ®Google Scholar
• Chen C-Y, Lien Y-T, Yeh H-H, et al. Comparison of adverse obstetric outcomes and maternity hospitalization among heroin-exposed and methadone-treated women in Taiwan. Int J Drug Policy. 2015;26(2):191–198.
   PubMed Web of Science ®Google Scholar
• Nørgaard M, Nielsson MS, Heide-Jørgensen U. Birth and neonatal outcomes following opioid use in pregnancy: a Danish population-based study. Subst Abuse Res Treat. 2015;9:SART. S23547.
   Web of Science ®Google Scholar
• Phibbs CS, Schmitt SK. Estimates of the cost and length of stay changes that can be attributed to one-week increases in gestational age for premature infants. Early Hum Dev. 2006;82(2):85–95.
   PubMed Web of Science ®Google Scholar
• Surman G, Newdick H, King A, et al. Annual report 2009, including data for births 1984 to 2003. Oxford: National Perinatal Epidemiology Unit; 2009.
   Google Scholar
• Rosenstein MG, Cheng YW, Snowden JM, et al. Risk of stillbirth and infant death stratified by gestational age. Obstet Gynecol. 2012;120(1):76–82.
   PubMed Web of Science ®Google Scholar
• Stoknes M, Andersen GL, Elkamil AI, et al. The effects of multiple pre-and perinatal risk factors on the occurrence of cerebral palsy. A Norwegian register based study. Eur J Paediatr Neurol. 2012;16(1):56–63.
   PubMed Web of Science ®Google Scholar
• Lemon LS, et al. Methadone versus buprenorphine for opioid use dependence and risk of neonatal abstinence syndrome. Epidemiol. 2018;29(2):261–268.
   PubMed Web of Science ®Google Scholar
• Soepatmi S. Developmental outcomes of children of mothers dependent on heroin or heroin/methadone during pregnancy. Acta Paediat. 1994;83(s404):36–39.
   Google Scholar
• Fricker HS, Segal S. Narcotic addiction, pregnancy, and the newborn. Am J Dis Child. 1978;132(4):360–366.
   PubMedGoogle Scholar
• Kuppermann M. Procedure-related miscarriages and Down syndrome–affected births: implications for prenatal testing based on women’s preferences. Obstetr Gynecol. 2000;96(4):511–516.
   PubMed Web of Science ®Google Scholar
• Carroll AE, Downs SM. Comprehensive cost-utility analysis of newborn screening strategies. Pediatrics. 2006;117(5 Pt 2):S287–S295.
   PubMed Web of Science ®Google Scholar
• Carroll AE, Downs SM. Improving decision analyses: parent preferences (utility values) for pediatric health outcomes. J Pediatr. 2009;155(1):21–25.e5.
   PubMed Web of Science ®Google Scholar
• Jones ES, Moore BA, Sindelar JL, et al. Cost analysis of clinic and office-based treatment of opioid dependence: results with methadone and buprenorphine in clinically stable patients. Drug Alcohol Depend. 2009;99(1–3):132–140.
   PubMed Web of Science ®Google Scholar
• Jiang R, Lee I, Lee TA, et al. The societal cost of heroin use disorder in the United States. PloS One. 2017;12(5):e0177323.
   PubMed Web of Science ®Google Scholar
• Phibbs CS, Schmitt SK, Cooper M, et al. Birth hospitalization costs and days of care for mothers and neonates in California, 2009–2011. J Pediatr. 2019;204:118–125.e14.
   PubMed Web of Science ®Google Scholar
• Flick A, de la Torre L, Roca L, et al. An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor. Am J Perinatol. 2010;27(01):053–059.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention (CDC). Economic costs associated with mental retardation, cerebral palsy, hearing loss, and vision impairment–United States, 2003. MMWR. Morb Mortal Wkly Rep. 2004;53(3):57.
   PubMedGoogle Scholar
• Bureau of Labor Statistics, U.S. Department of Labor. Women’s earnings 1979–2012. The Economics Daily. 2013.
   Google Scholar
• Gold KJ, Sen A, Xu X. Hospital costs associated with stillbirth delivery. Matern Child Health J. 2013;17(10):1835–1841.
   PubMed Web of Science ®Google Scholar
• Statistics USBoL. Consumer price index for all urban consumers: medical care in U.S. City Average (CPIMEDSL). St. Louis: FRED, Federal Reserve Bank of St. Louis; 2020.
   Google Scholar
• Sanders GD, Neumann PJ, Basu A, et al. Recommendations for conduct, methodological practices, and reporting of cost-effectiveness analyses: second panel on cost-effectiveness in health and medicine. JAMA. 2016;316(10):1093–1103.
   PubMed Web of Science ®Google Scholar
• Team IS. Variations in reproductive events across life: a pooled analysis of data from 505 147 women across 10 countries. Hum Reprod. 2019;34(5):881–893.
   PubMed Web of Science ®Google Scholar
• World Health Organization. World health statistics 2016: monitoring health for the SDGs sustainable development goals. Geneva: World Health Organization; 2016.
   Google Scholar
• Rodriguez MI, Caughey AB. Cost-effectiveness analyses and their role in improving healthcare strategies. Curr Opin Obstet Gynecol. 2013;25(6):487–493.
   PubMed Web of Science ®Google Scholar
• Grossman MR, Berkwitt AK, Osborn RR, et al. An initiative to improve the quality of care of infants with neonatal abstinence syndrome. Pediatrics. 2017;139(6):e20163360.
   PubMed Web of Science ®Google Scholar
• Hser Y‐I, Evans E, Huang D, et al. Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial. Addiction. 2016;111(4):695–705.
   PubMed Web of Science ®Google Scholar
• Pinto H, Maskrey V, Swift L, et al. The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. J Subst Abuse Treat. 2010;39(4):340–352.
   PubMed Web of Science ®Google Scholar